Furthermore, we also measured the protein levels of four selected RBPs (GNL1, SPATS2L, RDM1, and FBXO17) in three glioma cell lines, one astrocytoma cell line (SW1088) and two glioblastoma cell lines (U251 and LN229). This evidence concerns the gene GNL1 and astrocytoma (excluding glioblastoma).